Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpi Jain

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
NPJ Vaccines|May 23, 2024
Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virusTeresa E Sorvillo, Elif Karaaslan, Florine E M Scholte, et al.
Virology|August 6, 2023
Development of a neutralization assay using a vesicular stomatitis virus expressing Nipah virus glycoprotein and a fluorescent proteinShilpi Jain, Michael K Lo, Markus H Kainulainen, et al.
JCI Insight|March 8, 2024
Age-related dysregulation of intestinal epithelium fucosylation is linked to an increased risk of colon cancerZhihan Wang, Pan Gao, Kai Guo, et al.
Antiviral Research|December 15, 2022
Tissue replication and mucosal swab detection of Sosuga virus in Syrian hamsters in the absence of overt tissue pathology and clinical diseaseStephen R Welch, Jana M Ritter, Amy J Schuh, et al.
Emerging Infectious Diseases|February 24, 2022
Relationship of SARS-CoV-2 Antigen and Reverse Transcription PCR Positivity for Viral CulturesDustin W Currie, Melisa M Shah, Phillip P Salvatore, et al.
Journal of Virology|October 31, 2025
Tissue tropism and functional adaptation of the SARS-CoV-2 spike protein in a fatal case of COVID-19Katherine E E Johnson, Sydney Stein, Rita Afriyie Boateng, et al.
The Journal of Infectious Diseases|July 3, 2021
Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction TestingTalya Shragai, Sarah E Smith-Jeffcoat, Mitsuki Koh, et al.
The Lancet. Infectious Diseases|February 3, 2025
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variantMehul S Suthar, Kelly E Manning, Madison L Ellis, et al.
Journal of the Pediatric Infectious Diseases Society|September 1, 2021
Antigen Test Performance Among Children and Adults at a SARS-CoV-2 Community Testing SiteLaura Ford, Melissa J Whaley, Melisa M Shah, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variantsShilpi Jain, Sanjeev Kumar, Lilin Lai, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
NPJ Vaccines|May 23, 2024
Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virusTeresa E Sorvillo, Elif Karaaslan, Florine E M Scholte, et al.
Virology|August 6, 2023
Development of a neutralization assay using a vesicular stomatitis virus expressing Nipah virus glycoprotein and a fluorescent proteinShilpi Jain, Michael K Lo, Markus H Kainulainen, et al.
JCI Insight|March 8, 2024
Age-related dysregulation of intestinal epithelium fucosylation is linked to an increased risk of colon cancerZhihan Wang, Pan Gao, Kai Guo, et al.
Antiviral Research|December 15, 2022
Tissue replication and mucosal swab detection of Sosuga virus in Syrian hamsters in the absence of overt tissue pathology and clinical diseaseStephen R Welch, Jana M Ritter, Amy J Schuh, et al.
Emerging Infectious Diseases|February 24, 2022
Relationship of SARS-CoV-2 Antigen and Reverse Transcription PCR Positivity for Viral CulturesDustin W Currie, Melisa M Shah, Phillip P Salvatore, et al.
Journal of Virology|October 31, 2025
Tissue tropism and functional adaptation of the SARS-CoV-2 spike protein in a fatal case of COVID-19Katherine E E Johnson, Sydney Stein, Rita Afriyie Boateng, et al.
The Journal of Infectious Diseases|July 3, 2021
Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction TestingTalya Shragai, Sarah E Smith-Jeffcoat, Mitsuki Koh, et al.
The Lancet. Infectious Diseases|February 3, 2025
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variantMehul S Suthar, Kelly E Manning, Madison L Ellis, et al.
Journal of the Pediatric Infectious Diseases Society|September 1, 2021
Antigen Test Performance Among Children and Adults at a SARS-CoV-2 Community Testing SiteLaura Ford, Melissa J Whaley, Melisa M Shah, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variantsShilpi Jain, Sanjeev Kumar, Lilin Lai, et al.
Pageof 6